Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials.
Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials. Lancet Oncol. 2014 Mar; 15(3):297-304.